This webinar will introduce the ADHEAR bone conduction system and discuss its potential advantages in treating OME. The functioning of the ADHEAR system will be reviewed, along with the treatment options for OME. This may be of particular relevance in the current situation where surgical options for treating OME are limited.
Key Learning Objectives:
Take home message:
The ADHEAR system offers a viable non-surgical management option for OME.
This webinar is sponsored by MED-EL
MED-EL is the global innovation leader in hearing loss solutions, restoring hearing for over 200,000 individuals worldwide. In 1975, Ingeborg and Erwin Hochmair began developing cochlear implants, founding the MED-EL company in 1990. State-of-the-art technology for bone conduction, middle ear, and cochlear implant systems is the result of over 40 years of research and development.
Our recently-launched innovations include the new ADHEAR, now with lockable battery door. Originally launched in 2017, the ADHEAR is a non-implantable bone conduction device for patients with conductive hearing loss, the first of its kind in the world. This revolutionary hearing system does not apply pressure to the skin, like other bone conduction devices.
In 2020, we released a new detailed white paper from our ADHEAR experts: The ADHEAR System – An innovative non-surgical bone conduction solution, and launched an ADHEAR podcast interview series.
To discover more about the ADHEAR and other MED-EL hearing solutions available, please visit medel.com/uk